Blood pressure pill may stop knee scarring after ACL surgery

NCT ID NCT07135687

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether losartan, a common blood pressure medicine that also reduces scarring, can prevent abnormal scar tissue (arthrofibrosis) in the knee after ACL reconstruction. About 144 adults having ACL surgery will take losartan or a placebo. The main goal is to see if it helps maintain knee range of motion over 12 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACL INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Anterior Cruciate Ligament Injuries

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Rush University Medical Center

    Chicago, Illinois, 60612, United States

    Contact

    Contact Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

    Contact Email: •••••@•••••